Style
Deep ValueTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Zymeworks Inc(ZYME) | 22,970,388 | $600.4M | 29.19% |
| 2 | Anaptysbio Inc(ANAB) | 7,880,094 | $531.9M | 25.86% |
| 3 | Aktis Oncology Inc(AKTS) | 4,824,469 | $155.5M | 7.56% |
| 4 | CG Oncology Inc(CGON) | 1,494,300 | $106.2M | 5.16% |
| 5 | Eton Pharmaceuticals Inc(ETON) | 2,171,938 | $78.6M | 3.82% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 83% | 91.7% | +8.7% |
| Unclassified | 17% | 8.3% | -8.7% |
Quarter-over-quarter weight changes by market cap
| Crispr Therapeutics AG(CRSP) |
| 1,389,276 |
| $75.8M |
| 3.68% |
| 7 | Oric Pharmaceuticals Inc(ORIC) | 6,728,116 | $72.9M | 3.54% |
| 8 | First Tracks Biotherapeutics(TRAX) | 3,174,519 | $63.9M | 3.11% |
| 9 | Lakefront Biotherapeutics NV(GLPG) | 1,667,119 | $50.0M | 2.43% |
| 10 | Neurogene Inc(NGNE) | 1,271,342 | $40.0M | 1.94% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 58.31% | 78.77% | +20.46% |
| Mid Cap | 22.79% | 9.19% | -13.6% |
| Unclassified | 17% | 8.3% | -8.7% |
| Micro Cap | 1.9% | 3.74% | +1.84% |
Quarter-over-quarter position changes